Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of ocular blood flow in metastatic colorectal cancer patients receiving anti-angiogenic therapy
2013-004606-26Phase 4Completed
- Sponsor
- Medical University of Vienna, Department of Internal Medicine I
- Start
- Feb 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bevacizumab in metastatic colon cancer (mCRC), sponsored by Medical University of Vienna, Department of Internal Medicine I. Primary endpoint: Retinal vessel diameters. Started Feb 2014; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colon cancer (mCRC)
Beyond the preview
Go deeper on 2013-004606-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004606-26.